Kulvinder Kochar Kaur¹*, Gautam Allahbadia² and Mandeep Singh³

¹Scientific Director, Dr Kulvinder Kaur Centre for Human Reproduction, Jalandhar, Punjab, India
²Scientific Director, Rotunda-A Centre for Human Reproduction, Mumbai, India
³Consultant Neurologist, Swami Satyan and Hospital, Jalandhar, Punjab, India

*Corresponding Author: Kulvinder Kochar Kaur, Scientific Director, Dr Kulvinder Kaur Centre for Human Reproduction, Jalandhar, Punjab, India.

Received: November 25, 2024; Published: December 01, 2024

Abstract

Ageing in variable organisms (specifically mammals) has been posited to start with encompasses nine shared properties, inclu sive of i) genomic instability, ii) telomere shortening attrition, iii) epigenetic changes, iv) decontrolling of nutrients sensing, v) mi tochondrial impairment, vi) cellular senescence, vii) changes of intercellular communications, viii)exhaustion of stem cells and ix) depletion of proteasis [1]. Immunosenescence has been thought to be an inimical event for over decades, in view of its propagating diminished capability of stimulating antibody, cellular reactions to infections along with vaccines with efficacy. Additionally, it has been thought to be an inimical event since it causes kinds of in flammation referred to as inflammageing. Recently we reviewed part of inflammageing and immunosenescence in in infectious dis eases.

References

1. Lopez-Otin C., et al. “The hallmarks of ageing”. Cell 153 (2013): 1194-1217.
2. Kulvinder Kochar Kaur., et al. “An Update on Ageing Associated Immunosenescence and Inflammageing in Infectious Diseases: A Narrative Review. accepted and Under Galley proof generation” (2024).
3. Centers for Disease Control and Prevention. Quick Stats: Death Rates* from Influenza and Pneumonia† Among Persons Aged ≥ 65 Years by Sex and Age Group—National Vital Statistics System, United States (2018).
4. Bartleson JM., et al. “SARS-CoV2, COVID19 and the ageing immune system”. Nature Ageing 1 (2021): 769-782.
5. Cho SJ., et al. “Ageing and lung disease”. Annual Review of Physiology 82 (2020): 433-459.
6. Gomez CR., et al. “The ageing innate immune system”. Current Opinion in Immunology 17 (2005): 457-462.
7. Shinjyo N and Kita K. “Infection, immunometabolism in the central nervous system:a possible mechanistic link between metabolic imbalance and dementia”. Frontiers in Cell Neuroscience 15 (2021): 765217.
8. Bender BSHIV. “Ageing as a model of immunosenescence”. The Journals of Gerontology. Series A, Biological Sciences 52 (1997): M261- M263.
9. Grifoni A., et al. “Impact of ageing on immunity in the context of COVID19, HIV and tuberculosis”. Frontiers in Immunology 14 (2023): 1146704.
10. Hatzakis A., et al. “Effect of thymic emigrants on progression of HIV-1 disease”. Lancet 355 (2000): 599-604.
11. Sottini A., et al. “Simultaneous quantification of - T cell receptor excision circles (TREC’s) and K deleting recombinant excision circles (KREC), by Real Time- PCR”. Journal of Visualized Experiments (JoVE) 94 (2014): 52184.
12. Quiros Rolan E., et al. “Effects of combined anti retroviral therapy on B and T cells release from production sites in long term treated HIV+ patients”. Journal of Translational Medicine 10 (2012): 94.
13. Guo L., et al. “The role of TEMRA cell- mediated immune senescence in the development and treatment of HIV disease”. Frontiers in Immunology 14 (2023): 1284293.
14. Elias Junior E., et al. “CD57 T cells associated with immunosenescence in adults living with HIV or AIDS”. Immunology 171 (2024): 146-153.
15. Turner CT., et al. “Persistent T cell repertoire perturbation and T cell activation in HIV after long term treatment”. Frontiers in Immunology 12 (2021): 634489.
16. Soares LS., et al. “Immunosenescence in chronic HIV infected patients impairs essential functions of their natural killer cells”. International Immunopharmacology 84 (2024): 106568.
17. Deeks SG., et al. “Immunosenescence and HIV”. Current Opinion in Immunology 24 (2012): 501-506.
18. Asghari F., et al. “Immunosenescence and inflammageingng in COVID19”. Viral Immunology 35 (2023): 579-592.
19. OECD Data. Influenza Vaccination Rates (2024).
20. Patel MM., et al. “Immune mediated attenuattion influenza illness after infection: opportunities and challenges”. Lancet Microbe 2 (2021): e715-e725.
21. Albright JM., et al. “Advanced age alters monocyte and macrophages responses”. Antioxidants and Redox Signaling 25 (2016): 805-815.
22. Hears AC., et al. “Ageing is associated with chronic innate immune activation and dysregulation of monocyte phenotype and functions”. Ageing Cell 11 (2012): 867-875.
23. McElhaney JE., et al. “The immune response influenza in older humans: beyond immunesenescence”. Immune Ageing 17 (2020): 10.
24. Jiang J., et al. “CD8Tcell responses to influenza virus infection”. Ageing Research Review 1043 (2011): 422-427.
25. Parks OB., et al. “Terminally exhausted CD8+T cells contribute to age dependent severity of respiratory virus infections”. Immune Ageing 20 (2023): 40.
26. Van de Sandt CE., et al. “Newborn and child like molecular signatures in older adults stem from TCR shifts across human lifespan”. Nature Immunology 24 (2023): 1890-1907.
27. Falsey AR and Walsh EE. “Respiratory syncytial virus infection in elderly adults”. Drug Ageing 22 (2005): 577-587.
28. Milinaric Galinovic G., et al. “Respiratory syncytial virus in the elderly”. European Journal of Clinical Microbiology and Infectious Diseases 15 (1996): 777-781.
29. Savic M., et al. “Respiratory syncytial virus disease burden in adults aged 60 years and older in high income countries :a systematic review and meta-analysis”. Influenza and Other Respiratory Viruses 24 (2023): 1890-1907.
30. Looney RJ., et al. “Effect of Ageing on cytokines production in response to respiratory syncytial virus”. Journal of Infectious Disease 185 (2002): 682-685.
31. Salaun B., et al. “T cells, more than antibodies may prevent symptoms developing from respiratory syncytial virus in older adults”. Frontiers in Immunology 14 (2023): 1260146.
32. Njue A., et al. “Systematic literature review of risk factors for poor outcomes amongst adults with respiratory syncytial virus infection in high income countries”. Open Forum Infectious Diseases 10 (2023): ofad514.
33. Watson A and Wilkenson TMA. “Respiratory viral infections in the elderly”. Therapeutic Advances in Respiratory Disease 13 (2021): 175346621995050.
34. Palaciol Pedrero MA., et al. “Ageing and options to halt declining immunity to viral infections”. Frontiers in Immunology 12 (2021): 681449.
35. Martin- Escolano R., et al. “Immunological and senescence in patients after spontaneous clearance of Hepatitis C virus : gender implications for long term health risk”. Immune Ageing 20 (2023): 62.
36. Guiannakoulis VG., et al. “Senescence in HBV-, HCV- and NAFLD mediated hepatocellular carcinoma and senotherapeutics: current evidence and future perspectives”. Cancers 13 (2021): 4732.
37. Kang TW., et al. “Senescence surveillance pre malignant hepatocytes limits liver cancer development”. Nature 479 (2011): 547-551.
38. Gao H., et al. “Age associated changes in innate adaptive immunity: role of the gut microbiota”. Frontiers in Immunology 15 (2021): 1421062.

Citation

Citation: Kulvinder Kochar Kaur., et al. “Ageing Associated Immunosenescence and Inflammageing - Cause for Greater Mortality in Infectious Diseases (Specifically Viral Diseases)". Acta Scientific Microbiology 8.1 (2025): 01-04.

Copyright

Copyright: © 2025 Kulvinder Kochar Kaur., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.